| 000 | 01831 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250515131220.0 | ||
| 264 | 0 | _c20081016 | |
| 008 | 200810s 0 0 eng d | ||
| 022 | _a1528-0020 | ||
| 024 | 7 |
_a10.1182/blood-2008-03-143412 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYanik, Gregory A | |
| 245 | 0 | 0 |
_aThe impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. _h[electronic resource] |
| 260 |
_bBlood _cOct 2008 |
||
| 300 |
_a3073-81 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xtherapeutic use |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInflammation |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPneumonia _xdrug therapy |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _xadministration & dosage |
| 650 | 0 | 4 | _aSyndrome |
| 650 | 0 | 4 |
_aTransplantation, Homologous _xadverse effects |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aHo, Vincent T | |
| 700 | 1 | _aLevine, John E | |
| 700 | 1 | _aWhite, Eric S | |
| 700 | 1 | _aBraun, Thomas | |
| 700 | 1 | _aAntin, Joseph H | |
| 700 | 1 | _aWhitfield, Joel | |
| 700 | 1 | _aCuster, Joseph | |
| 700 | 1 | _aJones, Dawn | |
| 700 | 1 | _aFerrara, James L M | |
| 700 | 1 | _aCooke, Kenneth R | |
| 773 | 0 |
_tBlood _gvol. 112 _gno. 8 _gp. 3073-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2008-03-143412 _zAvailable from publisher's website |
| 999 |
_c18141405 _d18141405 |
||